Article
Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
Medicine - 20 Aug 2021
Lv Yalei, Xu Mengyuan, Sun Yidan, Liu Yezhou, Zhao Lijuan, Liu Xuehui, Li Zixuan, Shi Gaiping, Jia Jinhai, Bi Lanfei, Ma Ning, Zhang Xiaolin, Qi Cheng
Abstract excerpt
BACKGROUND: Gastric cancer (GC) is a strong cause of global cancer mortality. Nucleotide excision repair (NER) can modulate platinum-based chemotherapeutic efficacy by removing drug-produced DNA damage. Some studies have found a link between excision repair cross complementation group 1 (ERCC1) rs2298881, one gene in NER pathway, and response to chemotherapy. However, the results have been disputed. METHODS: We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
